RU92004406A - Дипиридамол для лечения пролиферативных болезней - Google Patents

Дипиридамол для лечения пролиферативных болезней

Info

Publication number
RU92004406A
RU92004406A RU92004406/14A RU92004406A RU92004406A RU 92004406 A RU92004406 A RU 92004406A RU 92004406/14 A RU92004406/14 A RU 92004406/14A RU 92004406 A RU92004406 A RU 92004406A RU 92004406 A RU92004406 A RU 92004406A
Authority
RU
Russia
Prior art keywords
treatment
proliferative diseases
dipiridamol
local delivery
dipyridamole
Prior art date
Application number
RU92004406/14A
Other languages
English (en)
Other versions
RU2084224C1 (ru
Inventor
Фрэнсис Кауффман Раймонд
Пол Сайн Джей
Original Assignee
Эли Лилли Энд Компани
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/795,434 external-priority patent/US5270047A/en
Application filed by Эли Лилли Энд Компани filed Critical Эли Лилли Энд Компани
Publication of RU92004406A publication Critical patent/RU92004406A/ru
Application granted granted Critical
Publication of RU2084224C1 publication Critical patent/RU2084224C1/ru

Links

Claims (1)

  1. Способ ингибирования пролиферации клеток млекопитающих, который содержит локальную доставку ингибиторного количества дипиридамола. Ингибирование пролиферации клеток полезно для лечения пролиферативных болезней, таких, как сосудистый рестеноз, склеродермия, псориаз и ревматоидный артрит. Этот способ включает локальную доставку дипиридамола к пролиферативному месту различными способами, включая катетеры локальной доставки, специфические для места носители, имплантаты, прямую инъекцию или прямое применение.
RU9292004406A 1991-11-21 1992-11-16 Дипиридамол для лечения пролиферативных болезней RU2084224C1 (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US07/795.434 1991-11-21
US07/795,434 US5270047A (en) 1991-11-21 1991-11-21 Local delivery of dipyridamole for the treatment of proliferative diseases
US07/795434 1991-11-21

Publications (2)

Publication Number Publication Date
RU92004406A true RU92004406A (ru) 1995-01-09
RU2084224C1 RU2084224C1 (ru) 1997-07-20

Family

ID=25165502

Family Applications (1)

Application Number Title Priority Date Filing Date
RU9292004406A RU2084224C1 (ru) 1991-11-21 1992-11-16 Дипиридамол для лечения пролиферативных болезней

Country Status (12)

Country Link
US (2) US5270047A (ru)
EP (1) EP0543653A1 (ru)
JP (1) JPH05201862A (ru)
KR (1) KR930009607A (ru)
AU (1) AU661067B2 (ru)
CA (1) CA2083223A1 (ru)
HU (1) HU212422B (ru)
MX (1) MX9206610A (ru)
NO (1) NO924461L (ru)
RU (1) RU2084224C1 (ru)
TW (1) TW252917B (ru)
ZA (1) ZA928832B (ru)

Families Citing this family (89)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5843156A (en) * 1988-08-24 1998-12-01 Endoluminal Therapeutics, Inc. Local polymeric gel cellular therapy
US6515009B1 (en) 1991-09-27 2003-02-04 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US5811447A (en) 1993-01-28 1998-09-22 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US6251920B1 (en) 1993-05-13 2001-06-26 Neorx Corporation Prevention and treatment of cardiovascular pathologies
US6395494B1 (en) 1993-05-13 2002-05-28 Neorx Corporation Method to determine TGF-β
US5770609A (en) * 1993-01-28 1998-06-23 Neorx Corporation Prevention and treatment of cardiovascular pathologies
US6306421B1 (en) 1992-09-25 2001-10-23 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US5847007A (en) * 1993-05-13 1998-12-08 Neorx Corporation Prevention and treatment of pathologies associated with abnormally proliferative smooth muscle cells
US6663881B2 (en) * 1993-01-28 2003-12-16 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US5595722A (en) * 1993-01-28 1997-01-21 Neorx Corporation Method for identifying an agent which increases TGF-beta levels
US6491938B2 (en) 1993-05-13 2002-12-10 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
EP1447098A3 (en) * 1993-01-28 2005-06-29 Boston Scientific Limited Therapeutic inhibitor of vascular smooth muscle cells
US5981568A (en) * 1993-01-28 1999-11-09 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
KR101222904B1 (ko) * 1993-07-19 2013-01-17 안지오테크 파마슈티칼즈, 인코포레이티드 항맥관형성 조성물, 당해 조성물로 피복된 스텐트 및 당해 스텐트의 제조방법
US5886026A (en) * 1993-07-19 1999-03-23 Angiotech Pharmaceuticals Inc. Anti-angiogenic compositions and methods of use
US5521191A (en) * 1994-10-17 1996-05-28 Washington University Method for treatment of arterial stenosis
US5665591A (en) * 1994-12-06 1997-09-09 Trustees Of Boston University Regulation of smooth muscle cell proliferation
US6558798B2 (en) 1995-02-22 2003-05-06 Scimed Life Systems, Inc. Hydrophilic coating and substrates coated therewith having enhanced durability and lubricity
US7611533B2 (en) * 1995-06-07 2009-11-03 Cook Incorporated Coated implantable medical device
AU6277396A (en) 1995-06-07 1996-12-30 Neorx Corporation Prevention and treatment of cardiovascular pathologies with tamoxifen analogues
US7550005B2 (en) * 1995-06-07 2009-06-23 Cook Incorporated Coated implantable medical device
US20070203520A1 (en) * 1995-06-07 2007-08-30 Dennis Griffin Endovascular filter
US7867275B2 (en) * 1995-06-07 2011-01-11 Cook Incorporated Coated implantable medical device method
US6774278B1 (en) * 1995-06-07 2004-08-10 Cook Incorporated Coated implantable medical device
US7846202B2 (en) 1995-06-07 2010-12-07 Cook Incorporated Coated implantable medical device
US7896914B2 (en) * 1995-06-07 2011-03-01 Cook Incorporated Coated implantable medical device
AU716005B2 (en) * 1995-06-07 2000-02-17 Cook Medical Technologies Llc Implantable medical device
US5609629A (en) * 1995-06-07 1997-03-11 Med Institute, Inc. Coated implantable medical device
US5951586A (en) * 1996-05-15 1999-09-14 Medtronic, Inc. Intraluminal stent
DK0914102T3 (da) 1996-05-24 2006-01-09 Angiotech Pharm Inc Præparater og fremgangsmåder til behandling eller forebyggelse af syddomme i legemskanaler
US20060030826A1 (en) * 1996-06-04 2006-02-09 Vance Products Incorporated,d/b/a Cook Urological Incorporated Implantable medical device with anti-neoplastic drug
US20060025726A1 (en) * 1996-06-04 2006-02-02 Vance Products Incorporated, D/B/A Cook Urological Incorporated Implantable medical device with pharmacologically active layer
US20060052757A1 (en) * 1996-06-04 2006-03-09 Vance Products Incorporated, D/B/A Cook Urological Incorporated Implantable medical device with analgesic or anesthetic
US6530951B1 (en) 1996-10-24 2003-03-11 Cook Incorporated Silver implantable medical device
US6495579B1 (en) 1996-12-02 2002-12-17 Angiotech Pharmaceuticals, Inc. Method for treating multiple sclerosis
US6515016B2 (en) 1996-12-02 2003-02-04 Angiotech Pharmaceuticals, Inc. Composition and methods of paclitaxel for treating psoriasis
AU8700798A (en) 1997-08-26 1999-03-16 Technion Research & Development Foundation Ltd. Intravascular apparatus and method
US7208010B2 (en) * 2000-10-16 2007-04-24 Conor Medsystems, Inc. Expandable medical device for delivery of beneficial agent
US6241762B1 (en) 1998-03-30 2001-06-05 Conor Medsystems, Inc. Expandable medical device with ductile hinges
US7208011B2 (en) * 2001-08-20 2007-04-24 Conor Medsystems, Inc. Implantable medical device with drug filled holes
US20040254635A1 (en) * 1998-03-30 2004-12-16 Shanley John F. Expandable medical device for delivery of beneficial agent
CA2340652C (en) 1998-08-20 2013-09-24 Cook Incorporated Coated implantable medical device comprising paclitaxel
US6168619B1 (en) * 1998-10-16 2001-01-02 Quanam Medical Corporation Intravascular stent having a coaxial polymer member and end sleeves
US6293967B1 (en) 1998-10-29 2001-09-25 Conor Medsystems, Inc. Expandable medical device with ductile hinges
US6120847A (en) * 1999-01-08 2000-09-19 Scimed Life Systems, Inc. Surface treatment method for stent coating
US6419692B1 (en) 1999-02-03 2002-07-16 Scimed Life Systems, Inc. Surface protection method for stents and balloon catheters for drug delivery
US6156373A (en) 1999-05-03 2000-12-05 Scimed Life Systems, Inc. Medical device coating methods and devices
US6290673B1 (en) 1999-05-20 2001-09-18 Conor Medsystems, Inc. Expandable medical device delivery system and method
US6258121B1 (en) 1999-07-02 2001-07-10 Scimed Life Systems, Inc. Stent coating
EP1250166B1 (en) * 2000-01-25 2010-03-17 Edwards Lifesciences Corporation Delivery systems for treatment of restenosis and anastomotic intimal hyperplasia
US6764507B2 (en) 2000-10-16 2004-07-20 Conor Medsystems, Inc. Expandable medical device with improved spatial distribution
EP1935380B1 (en) 2000-10-16 2010-05-12 Conor Medsystems, Inc. Expandable medical device for delivery of beneficial agent
US7803149B2 (en) * 2002-07-12 2010-09-28 Cook Incorporated Coated medical device
US7077859B2 (en) 2000-12-22 2006-07-18 Avantec Vascular Corporation Apparatus and methods for variably controlled substance delivery from implanted prostheses
US6964680B2 (en) * 2001-02-05 2005-11-15 Conor Medsystems, Inc. Expandable medical device with tapered hinge
US20040073294A1 (en) * 2002-09-20 2004-04-15 Conor Medsystems, Inc. Method and apparatus for loading a beneficial agent into an expandable medical device
DE10115740A1 (de) * 2001-03-26 2002-10-02 Ulrich Speck Zubereitung für die Restenoseprophylaxe
DE10119680A1 (de) * 2001-04-20 2002-11-14 Boehringer Ingelheim Pharma Verwendung von Radikalfänger-Verbindungen zur Behandlung und Verhinderung von no-abhängigen Störungen der Mikrozirkulation
US7064130B2 (en) 2001-04-20 2006-06-20 Boehringer Ingelheim Pharma Gmbh & Co. Kg Use of radical-scavenging compounds for treatment and prevention of NO-dependent microcirculation disorders
US7842083B2 (en) 2001-08-20 2010-11-30 Innovational Holdings, Llc. Expandable medical device with improved spatial distribution
US7056338B2 (en) * 2003-03-28 2006-06-06 Conor Medsystems, Inc. Therapeutic agent delivery device with controlled therapeutic agent release rates
US20030073711A1 (en) * 2001-08-23 2003-04-17 Whitehead Clark M. Methods for treatment of scleroderma
PL370764A1 (en) * 2001-10-05 2005-05-30 Combinatorx, Incorporated Combinations for the treatment of immunoinflammatory disorders
US20030077310A1 (en) * 2001-10-22 2003-04-24 Chandrashekhar Pathak Stent coatings containing HMG-CoA reductase inhibitors
EP1308179A1 (en) * 2001-10-30 2003-05-07 Boehringer Ingelheim Pharma GmbH & Co.KG Improved endoprosthetic device
US20030083614A1 (en) * 2001-10-30 2003-05-01 Boehringer Ingelheim Pharma Kg Controlled release endoprosthetic device
TW200301135A (en) * 2001-12-27 2003-07-01 Otsuka Maryland Res Inst Inc Pharmaceutical compositions comprising a multifunctional phosphodiesterase inhibitor and an adenosine uptake inhibitor
CA2472188C (en) * 2002-01-18 2011-06-21 Control Delivery Systems, Inc. Polymeric gel system for the controlled delivery of codrugs
AU2003205315A1 (en) * 2002-01-22 2003-09-02 Endobionics, Inc. Methods and kits for delivering pharmaceutical agents into the coronary vascular adventitia
US7744584B2 (en) 2002-01-22 2010-06-29 Mercator Medsystems, Inc. Methods and kits for volumetric distribution of pharmaceutical agents via the vascular adventitia and microcirculation
US10441747B2 (en) 2002-01-22 2019-10-15 Mercator Medsystems, Inc. Methods and systems for inhibiting vascular inflammation
US7097850B2 (en) 2002-06-18 2006-08-29 Surmodics, Inc. Bioactive agent release coating and controlled humidity method
DE10244847A1 (de) 2002-09-20 2004-04-01 Ulrich Prof. Dr. Speck Medizinische Vorrichtung zur Arzneimittelabgabe
US20040127976A1 (en) * 2002-09-20 2004-07-01 Conor Medsystems, Inc. Method and apparatus for loading a beneficial agent into an expandable medical device
US20040162542A1 (en) * 2002-12-03 2004-08-19 Endobionics, Inc. Methods and systems for treating the vasculature with estrogens
WO2004069254A2 (en) * 2003-02-07 2004-08-19 Boehringer Ingelheim International Gmbh Use of dipyridamole or mopidamole for treatment and prevention of mmp-9-dependent disorders
EP2272544A1 (en) 2003-03-28 2011-01-12 Conor Medsystems, Inc. Implantable medical device with beneficial agent concentration gradient
US7169179B2 (en) * 2003-06-05 2007-01-30 Conor Medsystems, Inc. Drug delivery device and method for bi-directional drug delivery
US7785653B2 (en) * 2003-09-22 2010-08-31 Innovational Holdings Llc Method and apparatus for loading a beneficial agent into an expandable medical device
US20050112199A1 (en) * 2003-09-24 2005-05-26 Mahesh Padval Therapeutic regimens for administering drug combinations
TW200517114A (en) * 2003-10-15 2005-06-01 Combinatorx Inc Methods and reagents for the treatment of immunoinflammatory disorders
CA2652773A1 (en) * 2006-05-22 2007-12-06 Combinatorx, Incorporated Methods and compositions for the treatment of diseases or conditions associated with increased c-reactive protein, interleukin-6, or interferon-gamma levels
WO2009038708A1 (en) * 2007-09-19 2009-03-26 Combinatorx, Incorporated Therapeutic regimens for the treatment of immunoinflammatory disorders
KR20100121601A (ko) * 2007-12-17 2010-11-18 콤비네이토릭스, 인코포레이티드 면역염증성 질환의 치료를 위한 치료요법
CN109996549A (zh) 2016-09-22 2019-07-09 墨卡托医疗系统公司 使用坦罗莫司治疗再狭窄
JP7137584B2 (ja) 2017-05-26 2022-09-14 マーケイター メドシステムズ， インコーポレイテッド 再狭窄の処置のための併用療法
CN111760174B (zh) 2018-03-14 2023-08-25 墨卡托医疗系统公司 用于局部药物递送的医疗器械和医疗方法
US20240166770A1 (en) * 2019-10-18 2024-05-23 Yale University Compositions and methods for inhibition of cell-penetrating antibodies
CN113244395B (zh) * 2020-02-10 2024-07-23 广州市妇女儿童医疗中心 纤维化疾病机制及其治疗药物

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3124090A1 (de) * 1981-06-19 1983-01-05 Dr. Karl Thomae Gmbh, 7950 Biberach Neue orale dipyridamolformen
CA1208516A (en) * 1982-04-02 1986-07-29 Harvey Wolinsky Methods and apparatus for relieving arterial constrictions
US4824436A (en) * 1985-04-09 1989-04-25 Harvey Wolinsky Method for the prevention of restenosis
WO1990001969A1 (en) * 1988-08-24 1990-03-08 Slepian Marvin J Biodegradable polymeric endoluminal sealing
US4938763B1 (en) * 1988-10-03 1995-07-04 Atrix Lab Inc Biodegradable in-situ forming implants and method of producing the same
ES2078936T3 (es) * 1989-01-31 1996-01-01 Bard Inc C R Cateter y metodo para aplicar localmente la medicacion a la pared de un vaso sanguineo o de otro lumen corporal.
US5102668A (en) * 1990-10-05 1992-04-07 Kingaform Technology, Inc. Sustained release pharmaceutical preparation using diffusion barriers whose permeabilities change in response to changing pH
US5171217A (en) * 1991-02-28 1992-12-15 Indiana University Foundation Method for delivery of smooth muscle cell inhibitors

Similar Documents

Publication Publication Date Title
RU92004406A (ru) Дипиридамол для лечения пролиферативных болезней
KR930009607A (ko) 증식성 질환의 치료를 위한 다이피리다몰
MX9206577A (es) COMPOSICIóN FARMACEUTICA PARA INHIBIR EL CRECIMIENTO DE CELULAS TUMORALES
ATE202140T1 (de) Hemmung der neovaskulasierung durch vegf- spezifische oligonukleotide
ATE124421T1 (de) Verfahren zur wachstumshemmung von stammzellen.
NO991951L (no) Tienopyrimidiner med fosfodiesterase V-inhiberende virkning
DE69325772D1 (de) Implantierbarer Herzschrittmacher mit anpassbarem AV-Intervall zur Behandlung von Kardiomyopathie
DE69631423D1 (de) Chinolone und deren therapeutische verwendung
CA2109208A1 (en) Radiolabeled metal-binding protein for the treatment of arthritis
EP0702557A4 (en) INHIBITORS OF SMOOTH VASCULAR MUSCLE CELLS FOR THERAPEUTIC USE
ATE256741T1 (de) Pflanzen mit modifizierter reaktion auf ethylen
DE69201660D1 (de) Verwendung von Acetyl L-Carnitin zur therapeutischen Behandlung von Coma.
IL110068A (en) Seed treatment by phosphorous acid or one of its salts and seeds thus treated
DE69028320D1 (de) Illudin-analoge, verwendet als antitumormittel
FI865163A0 (fi) Peptider innehaollande grupper av sulfatester.
IT8721367A0 (it) Apparecchiatura di trattamento fisico e/o chimico ad elevata potenzialita' in un impianto automatico per la produzione diprodotti.
DE59209865D1 (de) Elektrodenkatheter mit einer Anordung zum intravaskulären Implantieren oder Explantieren des Elektrodenkatheters
IE873084L (en) Peptides with sulfate ester groups
MX9304626A (es) Derivados heterociclicos utiles en el tratamiento de enfermedades cardiovasculares.
DK0658117T3 (da) Behandling af tumorer med neurotrofe faktorer og celleproliferationsinhibitorer
DK0572549T3 (da) Behandling af ikke-småcellet lungecarcinom
MX9301726A (es) Factor de crecimiento derivado de plaquetas monomerico y prevencion de estenosis o restenosis.
FR2707623B1 (fr) Procédé de traitement d'effluents azotés.
PL287547A1 (en) Mechanical and biological sewage treatment plant with active sludge zones
Lazurkina Sympathetic effect on the skeletal muscle studied by mitogenic irradiation registration.